426 related articles for article (PubMed ID: 29246611)
1. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
[TBL] [Abstract][Full Text] [Related]
2. Swallowing Outcomes Following Voice Therapy in Multiple System Atrophy with Dysphagia: Comparison of Treatment Efficacy with Parkinson's Disease.
Park A; Jang SJ; Kim NE; Kim TH; Sohn YH; Kim H; Cho SR
Dysphagia; 2022 Feb; 37(1):198-206. PubMed ID: 33666739
[TBL] [Abstract][Full Text] [Related]
3. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
El Sharkawi A; Ramig L; Logemann JA; Pauloski BR; Rademaker AW; Smith CH; Pawlas A; Baum S; Werner C
J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):31-6. PubMed ID: 11784821
[TBL] [Abstract][Full Text] [Related]
4. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
5. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
[TBL] [Abstract][Full Text] [Related]
6. Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.
Baldanzi C; Crispiatico V; Foresti S; Groppo E; Rovaris M; Cattaneo D; Vitali C
J Voice; 2022 Jul; 36(4):585.e1-585.e13. PubMed ID: 32819780
[TBL] [Abstract][Full Text] [Related]
7. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
[TBL] [Abstract][Full Text] [Related]
8. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
Wight S; Miller N
Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
[TBL] [Abstract][Full Text] [Related]
9. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
[TBL] [Abstract][Full Text] [Related]
10. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson's disease: A Phase 1 study.
Finnimore A; Theodoros D; Rumbach AF
Int J Lang Commun Disord; 2023 Mar; 58(2):241-255. PubMed ID: 36036751
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
Körner Gustafsson J; Södersten M; Ternström S; Schalling E
Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
[TBL] [Abstract][Full Text] [Related]
13. Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.
Nozaki S; Fujiu-Kurachi M; Tanimura T; Ishizuka K; Miyata E; Sugishita S; Imai T; Nishiguchi M; Furuta M; Yorifuji S
Prog Rehabil Med; 2021; 6():20210012. PubMed ID: 33644483
[TBL] [Abstract][Full Text] [Related]
14. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
15. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.
Dumer AI; Oster H; McCabe D; Rabin LA; Spielman JL; Ramig LO; Borod JC
J Int Neuropsychol Soc; 2014 Mar; 20(3):302-12. PubMed ID: 24524211
[TBL] [Abstract][Full Text] [Related]
16. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
Trials; 2020 May; 21(1):436. PubMed ID: 32460885
[TBL] [Abstract][Full Text] [Related]
18. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT
Ertan E; Gürvit HI; Hanağası HH; Bilgiç B; Tunçer MA; Yılmaz C
Logoped Phoniatr Vocol; 2022 Dec; 47(4):262-270. PubMed ID: 34287100
[No Abstract] [Full Text] [Related]
19. Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis.
Narayana S; Fox PT; Zhang W; Franklin C; Robin DA; Vogel D; Ramig LO
Hum Brain Mapp; 2010 Feb; 31(2):222-36. PubMed ID: 19639554
[TBL] [Abstract][Full Text] [Related]
20. The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders.
Fox CM; Ramig LO; Ciucci MR; Sapir S; McFarland DH; Farley BG
Semin Speech Lang; 2006 Nov; 27(4):283-99. PubMed ID: 17117354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
